Samsung Medical Center
| Corea del Sur | España | Turquía | |
| Trasplante de médula ósea | de $55,000 | de $71,782 | de $36,000 |
| Trasplante autólogo de médula ósea | de $42,000 | de $40,000 | de $31,500 |
| Trasplante alogénico de médula ósea de un donante no emparentado | de $145,000 | de $150,000 | de $80,000 |
| Trasplante alogénico de médula ósea de un donante emparentado | de $75,000 | de $13,670 | de $65,000 |
| Terapia CAR-T | de $385,000 | de $330,000 | de $150,000 |
Bookimed no añade cargos extra a los precios de los tratamientos de Linfoma. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Linfoma y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Linfoma.
Escrito por Anna Leonova
Escrito por Halina Shubala
Lymphoma chemotherapy in Korea achieves remission rates between 85% and 90% for early-stage patients. Specialized clinical studies report an 87.6% complete remission rate for Hodgkin’s lymphoma. Aggressive B-cell subtypes like DLBCL reach approximately 84% remission. Major Seoul centers use advanced protocols for these results.
Bookimed Expert Insight: Data shows a high concentration of expertise in Seoul. Facilities like Samsung Medical Center and Severance Hospital manage over 2 million patients annually. These high-volume centers report remission rates comparable to Western benchmarks. This is due to their rapid adoption of digital systems. Seoul National University Hospital has been fully digitalized since 2004. This digital accuracy helps specialists refine chemotherapy dosing for complex lymphoma subtypes.
Patient Consensus: Patients note that Korean protocols are intensive. They emphasize the importance of reaching clear PET scans early in the treatment process.
CAR T-cell therapy is available for lymphoma patients at several licensed medical centers in South Korea. Major institutions provide approved therapies like Kymriah and Yescarta for relapsed or refractory diffuse large B-cell lymphoma. Local centers often collaborate on domestic clinical trials to expand treatment accessibility.
Bookimed Expert Insight: While South Korea ranks eighth globally in medical requests, its oncology infrastructure is exceptionally concentrated. Samsung Medical Center and Severance Hospital manage over 6,000,000 patients combined each year. This massive volume allows these centers to maintain dedicated CAR T-cell units. Such specialization often leads to smoother logistics for complex cellular processing than smaller regional hubs.
Patient Consensus: Patients note it is important to confirm eligibility through telemedicine before traveling for aggressive B-cell lymphoma treatments. Many highlight that coordinating professional translation and post-treatment monitoring is essential for a smooth experience at Seoul hospitals.
Leading centers for lymphoma treatment in South Korea include Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital. These Seoul-based institutions provide advanced therapies like CAR-T cell therapy and hematopoietic stem cell transplants. Most facilities hold JCI or KOIHA accreditations for oncology excellence.
Bookimed Expert Insight: Patient volume often indicates specialized expertise in Korea. Severance Hospital and Samsung Medical Center handle high annual patient counts, exceeding 2,000,000 people each. Our data shows these large academic centers often centralize clinical trials for immunotherapy. Choosing a high-volume center in Seoul typically ensures access to newer drug-based protocols not available regionally.
Patient Consensus: Patients emphasize seeking second opinions at multiple Seoul-based clinics to confirm aggressive lymphoma diagnoses. Many note that major teaching hospitals provide better English-speaking support for international oncology coordination.
Integrating Western lymphoma therapies with Korean Traditional Medicine (KTM) is a standard practice in Seoul medical centers. Specialized hospitals combine chemotherapy or immunotherapy with acupuncture and herbal medicine. These protocols manage side effects like neuropathy and fatigue while supporting immune function during rigorous treatment cycles.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital use digital systems like BESTcare to coordinate complex treatments for millions of patients. Our data shows that top-tier Seoul facilities often have KTM-integrated oncology referrals nearby. Patients should choose JCI-accredited hospitals that offer multidisciplinary tumor boards. These boards ensure traditional herbs do not interfere with advanced treatments like CAR T-cell therapy.
Patient Consensus: Patients note that getting oncologist approval for mild herbal teas often helps with post-chemo recovery and nausea. Many advise sticking strictly to hospital-approved herbs rather than over-the-counter options to avoid dangerous drug interactions.
Patients must bring complete medical records, including pathology slides, digital imaging, and detailed treatment logs. These documents ensure accurate diagnostic review and prevent treatment delays. South Korean cancer centers require recent scans and certified translations to confirm lymphoma staging and previous chemotherapy cycles.
Bookimed Expert Insight: Advanced centers like Samsung Medical Center and Asan Medical Center handle massive patient volumes, often exceeding 180,000 annually. This high traffic means diagnostic departments prioritize digital records over paper files for faster processing. Patients should bring three physical copies of all records, but keeping everything on a USB drive is the most efficient way to ensure Korean oncologists can integrate your history into their digital BESTcare systems immediately.
Patient Consensus: Patients emphasize that bringing physical pathology slides is essential to avoid repetitive biopsies that can cost $2,000. It is also important to have all files translated into Korean or English at least four weeks before traveling.
Seoul and Incheon serve as the primary hubs for lymphoma care in South Korea. These cities host Joint Commission International-accredited centers. They specialize in CAR T-cell therapy and bone marrow transplants. Patients access advanced diagnostics like PET-CT and cytogenetic analysis at these facilities.
Bookimed Expert Insight: Seoul centers demonstrate high-volume expertise rarely seen elsewhere. Asan Medical Center serves over 11,000 outpatients daily. This massive scale allows clinics like Seoul National University Bundang Hospital to implement digital systems that reduce medical errors. If seeking complex transplants, focusing on these high-capacity Seoul institutions ensures access to larger hematology teams.
Patient Consensus: Patients note that Seoul centers often provide faster treatment starts for aggressive lymphomas compared to US facilities. They frequently mention the benefit of having English-speaking coordinators at Samsung Medical Center to help navigate complex therapy schedules.
The Republic of Korea offers specialised CAR-T cell therapy for lymphoma. Major Seoul-based centres provide Kymriah and Yescarta for relapsed cases. Facilities like Samsung Medical Center and Seoul National University Hospital administer these engineered immune cell treatments. They focus on diffuse large B-cell lymphoma.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually. It also holds Newsweek Best Hospital rankings. This high volume across multidisciplinary units supports managed care for complex CAR-T side effects. Smaller centres may not match this specific intensive care infrastructure.
Patient Consensus: Patients note it is important to confirm clinical trial availability for specific lymphoma subtypes. It is also helpful to arrange telehealth follow-up with Korean specialists before returning home to Australia.
Leading South Korean hospitals for lymphoma treatment include Samsung Medical Center, Asan Medical Center, and Severance Hospital. These Seoul-based institutions provide CAR T-cell therapy and bone marrow transplants. Most major centres hold JCI accreditation. They manage over 1,000,000 patients annually with integrated oncology teams.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital offer a distinct advantage for Australian patients. Their JCI accreditation and massive surgical volumes provide high levels of clinical expertise. Severance Hospital alone performs approximately 45,800 operations yearly. This high frequency often leads to more refined clinical pathways for complex lymphoma cases.
Patient Consensus: Patients value Seoul tertiary hospitals for managing the entire pathway on-site. This includes everything from pathology and PET-CT scans to chemotherapy. They recommend confirming English-language support for medical reports to help with follow-up care in Australia.
Dozens of English-speaking lymphoma specialists practise at JCI-accredited tertiary centres in Seoul. These experts treat approximately 1,200 international patients annually. Most leading oncologists hold Western fellowships. Clinics like Samsung Medical Center and Severance Hospital provide dedicated coordinators for clear communication during chemotherapy or transplant cycles.
Bookimed Expert Insight: Many doctors understand clinical English. However, patients should select centres like Samsung Medical Center with 2,000,000+ annual patients. These high-volume hubs have the most refined international departments. Our data shows that top-tier facilities often employ coordinators who stay throughout chemo sessions. This is vital for managing immediate side effects or questions.
Patient Consensus: Patients note that many specialists speak basic English. Having a dedicated interpreter in the Republic of Korea helps patients fully understand complex diagnosis details and follow-up plans.
The Republic of Korea uses high-precision imaging and cellular therapies for lymphoma staging and treatment. Major Seoul centres employ PET-CT scans, cytogenetic bone marrow analysis, and CAR T-cell therapy. Licensed facilities like Samsung Medical Center and Asan Medical Center provide these technologies within JCI-accredited infrastructures.
Bookimed Expert Insight: Many countries offer CAR T-cell therapy. South Korea has moved toward self-sufficiency with its homegrown therapy, Limcato. Samsung Medical Center and Asan Medical Center handle vast patient volumes. These often exceed 180,000 cases annually. This volume helps clinical teams build deep expertise in managing complex immunotherapy reactions and post-transplant recovery.
Patient Consensus: Patients in South Korea highlight that centres use PET-CT based staging for specific lymphoma subtypes. They note that hospital teams effectively coordinate bone marrow biopsies and pathology reviews for international visitors.
International patients in South Korea receive support through dedicated healthcare centres. These hubs provide multilingual coordination and streamlined medical paths. Facilities like Severance Hospital and Samsung Medical Center offer JCI-accredited care. These centres fast-track biopsies and PET-CT scans so lymphoma treatment starts within days of arrival.
Bookimed Expert Insight: High-volume centres like Samsung Medical Center serve over 2,000,000 patients annually. For lymphoma, this volume allows doctors to handle highly specific subtypes. Hospitals like SNUBH use the BESTcare digital system. This reduces medical errors by instantly sharing precise diagnostic data across multidisciplinary teams.
Patient Consensus: Patients note that larger tertiary hospitals provide the best practical help with paperwork and transport. To help with follow-up care in Australia, patients recommend requesting all pathology reports in English before leaving Korea.